Nuwellis (NUWE) Capital Expenditures Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 32.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.15% |
| Dec 31, 2025 | -38.06% |
| Sep 30, 2025 | 64.54% |
| Jun 30, 2025 | -28.62% |
| Dec 31, 2024 | -6.35% |
| Sep 30, 2024 | -31.93% |
| Jun 30, 2024 | -33.33% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | -33.80% |
| Sep 30, 2023 | -4.29% |
| Jun 30, 2023 | -0.65% |
| Mar 31, 2023 | -8.55% |
| Dec 31, 2022 | -9.93% |
| Sep 30, 2022 | -58.42% |
| Jun 30, 2022 | -54.53% |
| Mar 31, 2022 | 19.52% |
| Dec 31, 2021 | 10.06% |
| Sep 30, 2021 | -1.20% |
| Jun 30, 2021 | 8.17% |
| Mar 31, 2021 | -0.59% |
| Dec 31, 2020 | 19.74% |
| Sep 30, 2020 | -9.47% |
| Jun 30, 2020 | 37.51% |
| Dec 31, 2019 | 54.87% |
| Sep 30, 2019 | 55.74% |
| Jun 30, 2019 | 77.28% |
| Mar 31, 2019 | 72.41% |
| Dec 31, 2018 | -4.35% |
| Sep 30, 2018 | -11.21% |
| Jun 30, 2018 | 40.65% |
| Mar 31, 2018 | -7.49% |
| Dec 31, 2017 | -28.66% |
| Sep 30, 2017 | 26.45% |
| Jun 30, 2017 | -33.17% |
| Dec 31, 2016 | -67.87% |
| Sep 30, 2016 | 7.61% |
| Jun 30, 2016 | 37.95% |
| Mar 31, 2016 | -3.85% |
| Dec 31, 2015 | -2.63% |
| Sep 30, 2015 | 47.36% |
| Jun 30, 2015 | 8.51% |
| Mar 31, 2015 | -6.82% |
| Dec 31, 2014 | -29.52% |
| Sep 30, 2014 | 130.35% |
| Jun 30, 2014 | 23.01% |
| Mar 31, 2014 | 87.31% |